Back to Search
MONICA FORNIER, MD
MD
Medical Oncology Physician
NPI: 1720059751IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
219873(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1992
Research & Publications (20)
Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues.
PMID 18021476·Clin Breast Cancer·2007
6-review
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.
PMID 17200358·Clin Cancer Res·2007
3-trial
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.
PMID 17908977·Clin Cancer Res·2007
3-trial
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
PMID 16134178·Cancer·2005
8-other
Dose-dense adjuvant chemotherapy for primary breast cancer.
PMID 15743513·Breast Cancer Res·2005
8-other
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate.
PMID 15668276·Ann Oncol·2005
8-other
HER2 testing and correlation with efficacy of trastuzumab therapy.
PMID 12435204·Oncology (Williston Park)·2002
6-review
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
PMID 11751485·Clin Cancer Res·2001
3-trial
Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer.
PMID 11236027·Semin Oncol·2000
6-review
NCCN Task Force Report: Bone Health in Cancer Care.
PMID 19555589·J Natl Compr Canc Netw·2009
6-review
Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.
PMID 19367253·Clin Adv Hematol Oncol·2009
8-other
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.
PMID 19253021·J Cancer Res Clin Oncol·2009
3-trial
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.
PMID 18751888·Breast Cancer Res Treat·2009
3-trial
Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity.
PMID 19209027·Anticancer Drugs·2009
3-trial
Novel anti-tubulin cytotoxic agents for breast cancer.
PMID 19192956·Expert Rev Anticancer Ther·2009
6-review
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.
PMID 18952555·Clin Breast Cancer·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 205 E 64TH ST
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1720059751
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile